Understanding OUR Cytokine-Based Immunotherapy Candidates Our motivation extends to advancing a robust portfolio of programs aimed toward expanding the horizons of cytokine-based immunotherapy, specifically for cancers where treatment solutions remain limited. Make use of the links below to learn additional about our portfolio of cytokine-based immunotherapy candidates. Check out https://financefeeds.com/esma-chair-calls-for-a-shift-from-a-vicious-cycle-of-stagnation/